In this issue:
Gene-expression profiling in DLBCL
HSCT in paediatric hypodiploid ALL
WBRT vs ASCT for primary CNS lymphoma
Lenalidomide + azacitidine after alloHSCT for AML
Childhood ALL with late bone marrow relapses
6 or 8 rituximab doses in CHOP-treated aggressive B-cell lymphoma?
(R)-GEMOX for primary CNS lymphoma
Azacitidine maintenance improves DFS in elderly AML
Ibrutinib + palbociclib in previously treated MCL
Ibrutinib, bendamustine, and rituximab in relapsed CLL/SLL
Please login below to download this issue (PDF)